Procter & Gamble CO Form 4 insider transactions

Procter & Gamble Director M. Brett Biggs reported the acquisition of 1,475 shares of common stock through a Restricted Stock Unit grant.

Procter & Gamble Director Craig Arnold was awarded 1,475 shares of common stock as Restricted Stock Units under the company's incentive plan.

Procter & Gamble Director Bertrand Marc Allen was granted 1,475 Restricted Stock Units as part of the company's 2019 Stock and Incentive Compensation Plan.

Procter & Gamble's Chief Financial Officer, Andre Schulten, sold 4,252 shares of common stock to cover tax obligations related to a Restricted Stock Unit Award.

Procter & Gamble's Chairman, President, and CEO, Jon R. Moeller, reported the sale of 11,684 common shares at $152.2317 per share to cover tax obligations.

Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble Co, sold 490 shares of common stock to cover tax obligations related to a Restricted Stock Unit award.

Procter & Gamble's CEO of Beauty, Alexandra R. Keith, sold a portion of her common stock to cover tax obligations related to a restricted stock unit award.

Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, sold 3,986 shares of common stock to cover tax obligations related to a Restricted Stock Unit Award settlement.

Jennifer L. Davis, CEO of Health Care at Procter & Gamble, sold 3,227 shares of common stock to cover tax obligations related to a restricted stock unit award.

Procter & Gamble's CEO of Grooming, Gary A. Coombe, sold 3,535 shares of common stock to cover tax obligations related to a restricted stock unit award.

Procter & Gamble's Chief Legal Officer, Susan Street Whaley, disposed of 2,408 shares of common stock to cover tax obligations related to a previous Restricted Stock Unit grant.

Procter & Gamble CEO Jon R. Moeller acquired 12,241 shares of common stock and 169,684 stock options, signaling strong confidence in the company's future.

Susan Street Whaley, Procter & Gamble's Chief Legal Officer, was granted 5,742 restricted stock units and 26,531 stock options.

Procter & Gamble's Chief Financial Officer, Andre Schulten, was awarded 5,602 restricted stock units and 77,648 stock options on October 1, 2025.

Procter & Gamble's CEO of Fabric & Home Care, Sundar G. Raman, reported the acquisition of 68,869 stock options and updated his common stock holdings.

Procter & Gamble's Chief Research, Development & Innovation Officer, Moses Victor Javier Aguilar, acquired 4,921 restricted stock units and 22,738 stock options.

Procter & Gamble's CEO of Grooming, Gary A. Coombe, was awarded 3,373 restricted stock units and 46,754 stock options as part of his compensation plan.

Procter & Gamble's CEO of Baby, Fem & Family Care, Ma. Fatima Francisco, reported acquiring stock options and increasing beneficial ownership of common stock.

Jennifer L. Davis, CEO of Health Care at Procter & Gamble, acquired 68,869 stock options and saw an adjustment to her retirement plan holdings.

Procter & Gamble's SVP and Chief Accounting Officer, Matthew W. Janzaruk, reported the acquisition of 13,779 stock options and adjustments to common stock holdings.

Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, acquired 22,849 restricted stock units and 105,581 stock options as part of compensation.

Procter & Gamble's CEO of Beauty, R. Alexandra Keith, reported the acquisition of 76,501 stock options and updated common stock holdings.

Procter & Gamble's Chief Brand Officer, Marc S. Pritchard, acquired 49,065 stock options with an exercise price of $153.18, effective October 1, 2025.

Procter & Gamble's Chief Human Resources Officer, Balaji Purushothaman, acquired 42,670 stock options and reported existing common stock holdings.

Procter & Gamble's Chief Human Resources Officer, Balaji Purushothaman, acquired 11,420 stock options and holds over 18,000 shares of common stock.

Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, was granted 26,231 stock options with an exercise price of $156.83, exercisable from September 15, 2028.

Procter & Gamble's Chief Research, Development & Innovation Officer, Moses Victor Javier Aguilar, was granted 6,852 stock options.

Procter & Gamble Director Patricia A. Woertz was awarded 189 Restricted Stock Units as part of the company's incentive plan.

Procter & Gamble Director Christopher J. Kempczinski received an award of 197 Restricted Stock Units, increasing his direct beneficial ownership to 9,166.4401 shares.

Procter & Gamble Director Craig Arnold received an award of 189 Restricted Stock Units, including dividend equivalents, effective September 9, 2025.